
Chiu discusses factors affecting adoption of the FDA-approved epi-on therapy, from clinic setup to insurance coverage, while highlighting its safety and efficacy.
Gloria B. Chiu, OD, FAAO, FSLS, is associate professor of clinical ophthalmology, USC Roski Eye Institute, Keck Medicine of USC, Los Angeles, CA; and adjunct faculty, Southern California College of Optometry in Fullerton, CA.

Chiu discusses factors affecting adoption of the FDA-approved epi-on therapy, from clinic setup to insurance coverage, while highlighting its safety and efficacy.

Equally important is that any symptoms of ocular allergies should be addressed to reduce the frequency of eye rubbing.

Published: March 10th 2022 | Updated: